3.50 USD
▲+0.16+9.72%
2026-08-03
市值
$40.99M
市盈率
—
EPS
-0.73
股息率
—
52 周区间
1.98 – 9.99
成交量
70.57K
Beta
—
目标价
19.67
52W 低 1.9852W 高 9.99
价格走势
公司简介
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company’s products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-...